From July 1, 2024 to July 12, 2024, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 774,546 shares, representing 2.9% for KRW 2,999.57 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,520 KRW | +0.43% |
|
+1.15% | -14.36% |
1st Jan change | Capi. | |
---|---|---|
-14.36% | 7.05Cr | |
+25.40% | 4.55TCr | |
+34.52% | 2.45TCr | |
+27.12% | 1.65TCr | |
+21.19% | 1.47TCr | |
+71.91% | 1.43TCr | |
-0.05% | 678.76Cr | |
-11.84% | 673.29Cr | |
+18.15% | 586.92Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.